cycline d1
Recently Published Documents


TOTAL DOCUMENTS

11
(FIVE YEARS 0)

H-INDEX

4
(FIVE YEARS 0)

2016 ◽  
Vol 47 (2) ◽  
pp. 145-152 ◽  
Author(s):  
Mehmet Kanter ◽  
Gulay Turan ◽  
Ceyda Usta ◽  
Akin Usta ◽  
H. Hasan Esen ◽  
...  

2014 ◽  
Vol 45 (6) ◽  
pp. 679-687 ◽  
Author(s):  
Gulay Turan ◽  
Ceyda Sancakli Usta ◽  
Akin Usta ◽  
Mehmet Kanter ◽  
Lema Tavli ◽  
...  

2013 ◽  
Vol 140 (12) ◽  
pp. S640
Author(s):  
A. Finet-Benyair ◽  
M. Bagot ◽  
A. Bensussan ◽  
N. Dumaz
Keyword(s):  

2013 ◽  
Vol 32 (4) ◽  
pp. 1-8 ◽  
Author(s):  
Nasta Tanić ◽  
Vedrana Milinković ◽  
Tatjana Dramićanin ◽  
Milica Nedeljković ◽  
Tijana Stanković ◽  
...  

Summary Background: Breast cancer is the most common form of cancer in women. It arises from multiple genetic changes in oncogenes and tumor suppressor genes. Among so far studied oncogenes relatively few, including epdermal growth factor receptor (EGFR), cyclinD1 (CCND1)and cmyc, have been found to play an important role in progression of this type of human malignancy. The aim of this study was to examine the prognostic potential of CCND1, c-myc and EGFR amplification and their possible cooperation in breast carcinogenesis. Methods: Copy number analyses of CCND1 and c-myc genes were done by TaqMan based quantitative real time PCR. Am pli fication status of EGFR was determined by differential PCR. Results: Amplification of CCND1, c-myc and EGFR onco- gene has been found in 20.4%, 26.5% and 26.5% of breast cancer cases, respectively. Analysis showed that amplification of CCND1 oncogene was significantly associated with the stage II of disease while amplification of EGFR gene was sig- nificantly associated with overexpression of HER-2/neu. Tu- mour stage and expression of HER-2/neu appeared to be significant predictors of patient's outcome. Stage I patients lived significantly longer then stage III patients (p=0.04) while patients with FiER-2/neu overexpression had worse prognoses and lived significantly shorter (p=0.001). Finally, survival of patients who underwent hormone therapy only was significantly longer (p=0.001) then survival of the rest of patients. Conclusions: Amplification of CCND1 or EGFR oncogene is associated with the progression of breast cancer and bad prognosis. No co-ordination in amplification of CCND1, c- myc and EGFR oncogenes were established in this cohort of breast cancer patients.


Author(s):  
R. Freitas ◽  
J. Botelho ◽  
S. Astolfi filho ◽  
G. Anjos ◽  
L. Cattebeke ◽  
...  
Keyword(s):  

2013 ◽  
Vol 3 (6) ◽  
pp. 94 ◽  
Author(s):  
Abuhjar Abdussalam ◽  
Ronald G. Gerridzen

Lymphoma of the prostate, either primary or secondary, is veryrare. We report the case of an 82-year-old man with symptoms ofbladder outlet obstruction presumably due to benign prostatehyperplasia (BPH). He underwent an uneventful transurethral resectionof the prostate. Pathological review of the resected tissuedemonstrated substantial infiltration by an atypical lymphoid infiltratepositive for CD20, BCL2, CD5, k light chain and cycline D1.Histology and immunoprofile were consistent with mantle celllymphoma.


Gene ◽  
2012 ◽  
Vol 509 (1) ◽  
pp. 158-163 ◽  
Author(s):  
Soner Cander ◽  
Erdinç Ertürk ◽  
Mutlu Karkucak ◽  
Özen Öz Gül ◽  
Orhan Görükmez ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document